AT532505T - Inhaled and instillative use of semi-fluorinated alkanes as a drug carrier in intrapulmonary area - Google Patents

Inhaled and instillative use of semi-fluorinated alkanes as a drug carrier in intrapulmonary area

Info

Publication number
AT532505T
AT532505T AT08007640T AT08007640T AT532505T AT 532505 T AT532505 T AT 532505T AT 08007640 T AT08007640 T AT 08007640T AT 08007640 T AT08007640 T AT 08007640T AT 532505 T AT532505 T AT 532505T
Authority
AT
Austria
Prior art keywords
instillative
intrapulmonary
inhaled
semi
area
Prior art date
Application number
AT08007640T
Other languages
German (de)
Inventor
Hasso Meinert
Original Assignee
Novaliq Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaliq Gmbh filed Critical Novaliq Gmbh
Priority to EP20080007640 priority Critical patent/EP2110126B9/en
Publication of AT532505T publication Critical patent/AT532505T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-arylpropionic acids, ethacrynic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
AT08007640T 2008-04-18 2008-04-18 Inhaled and instillative use of semi-fluorinated alkanes as a drug carrier in intrapulmonary area AT532505T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP20080007640 EP2110126B9 (en) 2008-04-18 2008-04-18 Inhalative and instillative use of semi-fluorised alkanes as active ingredient carriers in the intrapulmonary area

Publications (1)

Publication Number Publication Date
AT532505T true AT532505T (en) 2011-11-15

Family

ID=39708796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08007640T AT532505T (en) 2008-04-18 2008-04-18 Inhaled and instillative use of semi-fluorinated alkanes as a drug carrier in intrapulmonary area

Country Status (14)

Country Link
US (1) US8986738B2 (en)
EP (1) EP2110126B9 (en)
JP (1) JP4990929B2 (en)
CN (1) CN101559229B (en)
AT (1) AT532505T (en)
AU (1) AU2009201137A1 (en)
BR (1) BRPI0900767A2 (en)
CA (1) CA2662943A1 (en)
DK (1) DK2110126T3 (en)
ES (1) ES2377152T3 (en)
HK (1) HK1135043A1 (en)
MX (1) MX2009003812A (en)
PT (1) PT2110126E (en)
TW (1) TWI417108B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
EP2332525A1 (en) 2009-11-23 2011-06-15 Novaliq GmbH Pharmaceutical composition comprising propofol
EP2335735A1 (en) 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
CN102869345B (en) 2010-03-17 2015-02-11 诺瓦利克有限责任公司 Pharmaceutical composition for treatment of increased intraocular pressure
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
PL2661280T3 (en) 2011-01-04 2019-05-31 Novaliq Gmbh O/w-emulsions comprising semifluorinated alkanes
AU2012260788B2 (en) 2011-05-25 2017-01-19 Novaliq Gmbh Pharmaceutical composition for administration to nails
JP6039145B2 (en) 2011-05-25 2016-12-07 ノバリック ゲーエムベーハー Topical pharmaceutical compositions in which the semi-fluorinated alkane underlying
JP6084987B2 (en) * 2012-01-23 2017-02-22 ノバリック ゲーエムベーハー It stabilized protein compositions based on Semifu' iodination alkane
KR20150004832A (en) * 2012-04-23 2015-01-13 키에시 파르마슈티시 엣스. 피. 에이. Method and system for the administration of a pulmonary surfactant by atomization
TR201812013T4 (en) 2012-09-12 2018-09-21 Novaliq Gmbh Eye wash compositions.
KR20150054997A (en) * 2012-09-12 2015-05-20 노바리크 게엠베하 Semifluorinated alkane compositions
AU2014295052B2 (en) 2013-07-23 2018-08-30 Novaliq Gmbh Stabilized antibody compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19536504C2 (en) * 1995-09-29 1999-09-23 H Meinert Use of fluorinated alkanes
US5869539A (en) 1996-04-17 1999-02-09 Board Of Regents, The University Of Texas System Emulsions of perfluoro compounds as solvents for nitric oxide (NO)
US6433040B1 (en) * 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6585957B1 (en) * 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
ES2387619T3 (en) 2004-04-19 2012-09-27 Centre National De La Recherche Scientifique (Cnrs) Lung surfactant supplements
DE102005055811A1 (en) * 2005-11-23 2007-05-31 Novaliq Gmbh Using composition containing semifluorinated alkane and/or siloxane for preservation or organs and limbs, ensures proper provision of oxygen

Also Published As

Publication number Publication date
EP2110126B1 (en) 2011-11-09
JP4990929B2 (en) 2012-08-01
EP2110126B9 (en) 2012-09-19
DK2110126T3 (en) 2012-02-27
CA2662943A1 (en) 2009-10-18
MX2009003812A (en) 2009-10-19
PT2110126E (en) 2012-02-20
EP2110126A1 (en) 2009-10-21
JP2009256353A (en) 2009-11-05
US20100008996A1 (en) 2010-01-14
ES2377152T9 (en) 2013-02-18
AU2009201137A1 (en) 2009-11-05
US8986738B2 (en) 2015-03-24
BRPI0900767A2 (en) 2010-12-28
ES2377152T3 (en) 2012-03-22
HK1135043A1 (en) 2014-03-07
CN101559229A (en) 2009-10-21
TW200950809A (en) 2009-12-16
CN101559229B (en) 2013-07-31
TWI417108B (en) 2013-12-01

Similar Documents

Publication Publication Date Title
AT455837T (en) Diluted introductions textile care products with thickeners and textile care products for use in present-anionic
BRPI0817082A2 (en) lacrimal implants and related methods
AT529990T (en) Notification of an instant messaging activity
AT485802T (en) Multidose phiolenanordnungen and adapters for
BRPI0906064A2 (en) "Peptide, process for obtaining a peptide of general formula (I) or pharmaceutical composition and cosmetic use of a peptide of general formula (I)"
BRPI0818946A2 (en) "Absorbent article"
BRPI0810554A2 (en) dental implant and dental component connection
BRPI0913560A2 (en) bag and container parts together
BRPI1012990A2 (en) "Analyte monitoring device and methods of use"
BRPI1011404A2 (en) mutants and uses thereof
BRPI0918591A2 (en) integrated display and management of data objects based on social parameters, time and space
BRPI0818311A2 (en) medical handler
BRPI0718543A2 (en) ocular devices and methods of manufacture and use thereof
BRPI0821499A2 (en) fluid filtration articles and methods of preparation and use thereof
BRPI1008137A2 (en) Glass fiber materials implanted with cnt and process therefor
BR112012031194A2 (en) cysteamine derivatives and their use in treating NASH
BR112013013668A2 (en) modulators 7-deazapurine histone methyltransferase, and methods of use thereof
BRPI0917891A2 (en) PD-1 antagonists and methods of use thereof
BRPI0717503A2 (en) transplant planner follicular units and methods of their use
BRPI0813741B1 (en) reaper combined with spreader fan and scattering method
AT519110T (en) Diagnostic nano sensor and its use in medicine
BRPI0819971A2 (en) Antibodies against influenza virus and methods of their use
BR112013010473A2 (en) composite structure, preparation process in accordance film process and
BRPI0718106B1 (en) selected absorbent article absorbent articles of personal care and medical absorbent articles to receive urine suspected of containing an analyte
BRPI0916269A2 (en) tissue modification device and its method of use